Close Menu

NEW YORK – An assay from Roche to test immunocompromised transplant recipients for adenovirus infections has been CE marked, the company announced on Wednesday. The test adds a fourth component to the firm's transplant monitoring virology menu and is now commercially available in countries accepting the CE mark.

The PCR-based adenovirus test provides detection and quantification of adenovirus, with calibration traceable to the World Health Organization international standard for adenovirus and reports in International Units per milliliter (IU/mL), the firm said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
23

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.